Cohort (LSE:CHRT) — Stock Price
Cohort (LSE:CHRT) is currently trading at GBX1154.00 GBX, up 1.23% today. Over the past 52 weeks, shares have ranged between GBX897.00 and GBX1474.00. This page tracks Cohort's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CHRT market cap overview.
Cohort (CHRT) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Cohort's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Cohort Income Statement — Revenue, Profit & Earnings by Year
Cohort's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2023 |
|---|---|---|---|---|---|
| Total Revenue | GBX306.39 Million | GBX270.04 Million | GBX202.53 Million | GBX199.55 Million | GBX182.71 Million |
| Cost of Revenue | GBX219.10 Million | GBX179.62 Million | GBX126.26 Million | GBX127.82 Million | GBX117.85 Million |
| Gross Profit | GBX87.29 Million | GBX90.42 Million | GBX76.27 Million | GBX71.73 Million | GBX64.86 Million |
| Research & Development | — | — | GBX17.68 Million | — | GBX12.72 Million |
| SG&A | GBX64.37 Million | GBX59.56 Million | GBX55.09 Million | GBX50.12 Million | GBX49.61 Million |
| Total Operating Expenses | GBX55.78 Million | GBX64.32 Million | GBX55.09 Million | GBX53.52 Million | GBX49.61 Million |
| Operating Income | GBX31.51 Million | GBX26.10 Million | GBX21.19 Million | GBX18.07 Million | GBX15.25 Million |
| EBITDA | GBX44.89 Million | GBX35.57 Million | GBX29.25 Million | GBX26.07 Million | GBX23.07 Million |
| EBIT | GBX31.51 Million | GBX27.07 Million | GBX21.53 Million | GBX18.41 Million | GBX15.24 Million |
| Interest Expense | GBX2.51 Million | GBX1.60 Million | GBX1.70 Million | GBX1.75 Million | GBX1.32 Million |
| Income Before Tax | GBX28.96 Million | GBX25.63 Million | GBX16.95 Million | GBX16.51 Million | GBX13.93 Million |
| Income Tax Expense | GBX4.68 Million | GBX6.01 Million | GBX1.66 Million | GBX3.23 Million | GBX2.67 Million |
| Net Income | GBX23.90 Million | GBX19.25 Million | GBX15.32 Million | GBX13.26 Million | GBX11.36 Million |
Cohort Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Cohort's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | GBX421.05 Million | GBX396.58 Million | GBX252.50 Million | GBX222.32 Million | GBX203.17 Million |
| Total Current Assets | GBX234.10 Million | GBX222.25 Million | GBX169.77 Million | GBX140.78 Million | GBX120.10 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | GBX136.52 Million | GBX88.98 Million | GBX79.38 Million | GBX57.74 Million | GBX56.16 Million |
| Inventory | GBX47.99 Million | GBX52.08 Million | GBX33.31 Million | GBX32.04 Million | GBX22.78 Million |
| Property, Plant & Equipment | — | — | — | GBX23.82 Million | GBX21.93 Million |
| Goodwill | GBX80.94 Million | GBX76.60 Million | GBX50.15 Million | GBX50.15 Million | GBX50.15 Million |
| Total Liabilities | GBX232.81 Million | GBX236.49 Million | GBX142.66 Million | GBX122.54 Million | GBX113.98 Million |
| Total Current Liabilities | GBX163.88 Million | GBX176.22 Million | GBX109.70 Million | GBX81.06 Million | GBX96.00 Million |
| Long-term Debt | GBX47.36 Million | GBX32.41 Million | GBX16.53 Million | GBX25.84 Million | GBX8.00K |
| Net Debt | GBX6.73 Million | GBX4.23 Million | GBX-14.65 Million | GBX-6.47 Million | GBX-851.00K |
| Total Stockholder Equity | GBX186.42 Million | GBX158.61 Million | GBX108.67 Million | GBX97.02 Million | GBX83.97 Million |
| Retained Earnings | GBX108.72 Million | GBX83.73 Million | GBX74.07 Million | GBX62.88 Million | GBX53.07 Million |
Cohort Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Cohort generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2023 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX11.74 Million | GBX51.18 Million | GBX23.02 Million | GBX29.97 Million | GBX16.52 Million |
| Capital Expenditures | GBX17.62 Million | GBX13.18 Million | GBX6.66 Million | GBX5.34 Million | GBX5.23 Million |
| Free Cash Flow | GBX-5.88 Million | GBX38.00 Million | GBX16.36 Million | GBX24.63 Million | GBX11.29 Million |
| Investing Cash Flow | GBX-11.73 Million | GBX-93.65 Million | GBX-6.16 Million | — | GBX-6.11 Million |
| Financing Cash Flow | GBX7.31 Million | GBX46.18 Million | GBX-16.92 Million | GBX-16.34 Million | GBX-10.57 Million |
| Dividends Paid | GBX7.70 Million | GBX6.48 Million | GBX5.60 Million | GBX5.43 Million | GBX5.12 Million |
| Stock-Based Compensation | GBX1.20 Million | GBX698.00K | GBX1.11 Million | GBX1.60 Million | GBX658.00K |
| Depreciation | GBX13.38 Million | GBX8.50 Million | GBX7.72 Million | GBX7.66 Million | GBX7.82 Million |
| Change in Cash | GBX-25.07 Million | GBX-1.16 Million | GBX-1.79 Million | GBX7.60 Million | GBX1.09 Million |
Cohort Earnings History — EPS Actual vs. Analyst Estimates
Track Cohort's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 09, 2025 | 0.16 | — | — |
| Aug 20, 2025 | 0.26 | 0.00 | — |
| Jul 16, 2025 | 0.36 | — | — |
| Dec 11, 2024 | 0.17 | 0.00 | — |
| Jul 21, 2023 | 0.00 | 0.00 | — |
| Dec 14, 2022 | 0.03 | — | — |
| Jul 28, 2022 | 0.22 | — | — |
| Dec 13, 2021 | -0.02 | — | — |